Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET/CT metabolic response in advanced CRC
NCT02618850Unknown
- Sponsor
- National Cancer Institute
- Start
- Apr 2014
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by National Cancer Institute. Primary endpoint: Change from baseline in highest value SUVmax at 2 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT02618850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02618850.